This brand name is authorized in Turkey
The drug NERISONA-C contains a combination of these active pharmaceutical ingredients (APIs):
1
Diflucortolone
UNII 1A63Z067C8 - DIFLUCORTOLONE VALERATE
|
Diflucortolone is a topically acting fluoridated corticosteroid which suppresses inflammation in inflammatory and allergic skin conditions and alleviates the subjective complaints such as itching, burning and pain. |
2
Chlorquinaldol
UNII D6VHC87LLS - CHLORQUINALDOL
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
D07BC04 | Diflucortolone and antiseptics | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07B Corticosteroids, combinations with antiseptics → D07BC Corticosteroids, potent, combinations with antiseptics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: TR | ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu | Identifier(s): 8699514350293, 8699514350309, 8699514350323 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.